Trial NCT01379521

View at ClinicalTrials.gov 
Org. Study IDs: CRAD001OHK02

Last trial update was posted on 2017-05-03

MeSH Interventions

Everolimus

MeSH Conditions

Carcinoma Carcinoma, Hepatocellular

Other Conditions

Hepatocellular Carcinoma

Stopping Reasons

The study was terminated due to low enrollment. This resulted in the study being underpowered and inconclusive.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID